{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:10:19Z","timestamp":1793243419519,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.phrs.2024.107526","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T03:52:51Z","timestamp":1732938771000},"page":"107526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma"],"prefix":"10.1016","volume":"210","author":[{"given":"Xinyue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinmei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2024.107526_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca. Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.phrs.2024.107526_bib2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000509424","article-title":"Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)","volume":"9","author":"Zhou","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.phrs.2024.107526_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, Regional and National Burden of Primary Liver Cancer by Subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12916-017-0815-7","article-title":"Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals","volume":"15","author":"Baumert","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.phrs.2024.107526_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1378423","article-title":"Editorial: Precision Medicine in Viral Hepatitis: Progress and Prospects towards Elimination","volume":"14","author":"Fern\u00e1ndez-Rodr\u00edguez","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.phrs.2024.107526_bib6","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.cgh.2024.02.028","article-title":"Validation of the Texas hepatocellular carcinoma risk index predictive model for hepatocellular carcinoma in Asian cohort","volume":"22","author":"Yoo","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107526_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4254\/wjh.v15.i2.180","article-title":"Antioxidant and anti-inflammatory agents in chronic liver diseases: molecular mechanisms and therapy","volume":"15","author":"Zhang","year":"2023","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107526_bib8","article-title":"A Review of Phyllanthus urinaria L. in the Treatment of Liver Disease: Viral Hepatitis, Liver Fibrosis\/Cirrhosis and Hepatocellular Carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107526_bib9","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic Reprogramming in Liver Fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107526_bib10","article-title":"Risk Factors Related to Low-Level Viraemia in Chronic Hepatitis B Patients Receiving Entecavir Treatment","volume":"14","author":"Li","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.phrs.2024.107526_bib11","unstructured":"Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries - PubMed. \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/31306800\/\u3009 (accessed 2024-10-31)."},{"key":"10.1016\/j.phrs.2024.107526_bib12","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pharmtox-020524-012013","article-title":"Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy","author":"Gilgenkrantz","year":"2024","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107526_bib13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jvh.12838","article-title":"Delayed Viral Suppression during Antiviral Therapy Is Associated with Increased Hepatocellular Carcinoma Rates in HBeAg-Positive High Viral Load Chronic Hepatitis B","volume":"25","author":"Nam","year":"2018","journal-title":"J. VIRAL Hepat."},{"issue":"5","key":"10.1016\/j.phrs.2024.107526_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000530495","article-title":"Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)","volume":"12","author":"Zhou","year":"2023","journal-title":"Liver Cancer"},{"issue":"9","key":"10.1016\/j.phrs.2024.107526_bib15","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1097\/MCG.0000000000000162","article-title":"Cirrhosis Regression in Patients With Viral Hepatitis B and C A Systematic Review","volume":"48","author":"Manne","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107526_bib16","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107526_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev-med-042220-021121","article-title":"Hepatocellular Carcinoma Immunotherapy","volume":"73","author":"Sperandio","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.phrs.2024.107526_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/JHC.S351038","article-title":"p Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma \/P","volume":"9","author":"Xue","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13046-024-03133-5","article-title":"Aptamer-Functionalized Triptolide with Release Controllability as a Promising Targeted Therapy against Triple-Negative Breast Cancer","volume":"43","author":"Chen","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.phrs.2024.107526_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/molecules21050559","article-title":"The traditional medicine and modern medicine from natural products","volume":"21","author":"Yuan","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2024.107526_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13020-018-0177-x","article-title":"Techniques for Extraction and Isolation of Natural Products: A Comprehensive Review","volume":"13","author":"Zhang","year":"2018","journal-title":"Chin. Med."},{"issue":"20","key":"10.1016\/j.phrs.2024.107526_bib22","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.3390\/nu14204252","article-title":"Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery","volume":"14","author":"Kim","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.phrs.2024.107526_bib23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.44.4.972-977.2000","article-title":"Antimalarial Bioavailability and Disposition of Artesunate in Acute Falciparum Malaria","volume":"44","author":"Newton","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2024.107526_bib24","doi-asserted-by":"crossref","unstructured":"Ansari, M.T.; Saify, Z.S.; Sultana, N.; et al. Malaria and Artemisinin Derivatives: An Updated Review. Mini-Rev. Med. Chem. 13 (13), 1879\u20131902. https:\/\/doi.org\/\u300810.2174\/13895575113136660097\u3009.","DOI":"10.2174\/13895575113136660097"},{"key":"10.1016\/j.phrs.2024.107526_bib25","article-title":"Artesunate Improves Glucose and Lipid Metabolism in Db\/Db Mice by Regulating the Metabolic Profile and the MAPK\/PI3K\/Akt Signalling Pathway","volume":"126","author":"Chen","year":"2024","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.phrs.2024.107526_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111108","article-title":"Artesunate-Loaded Solid Lipid Nanoparticles Resist Esophageal Squamous Cell Carcinoma by Inducing Ferroptosis through Inhibiting the AKT\/mTOR Signaling","volume":"117","author":"Xia","year":"2024","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib27","first-page":"1","article-title":"Artesunate Suppresses Th17 Response via Inhibiting IRF4-Mediated Glycolysis and Ameliorates Sjog\u0308ren\u2019s Syndrome","volume":"7","author":"Xiao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41467-024-45452-3","article-title":"Artesunate Treats Obesity in Male Mice and Non-Human Primates through GDF15\/GFRAL Signalling Axis","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107526_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107705","article-title":"Artesunate-Induced ATG5-Related Autophagy Enhances the Cytotoxicity of NK92 Cells on Endometrial Cancer Cells via Interactions between CD155 and CD226\/TIGIT","volume":"97","author":"Zhang","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12951-022-01676-3","article-title":"Synergetic Delivery of Artesunate and Isosorbide 5-Mononitrate with Reduction-Sensitive Polymer Nanoparticles for Ovarian Cancer Chemotherapy","volume":"20","author":"Li","year":"2022","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12964-024-01759-8","article-title":"Artesunate Induces Melanoma Cell Ferroptosis and Augments Antitumor Immunity through Targeting Ido1","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal. CCS"},{"key":"10.1016\/j.phrs.2024.107526_bib32","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.ijbiomac.2020.08.198","article-title":"Artesunate, as a HSP70 ATPase Activity Inhibitor, Induces Apoptosis in Breast Cancer Cells","volume":"164","author":"Pirali","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2024.107526_bib33","article-title":"Artesunate Promoted Anti-Tumor Immunity and Overcame EGFR-TKI Resistance in Non-Small-Cell Lung Cancer by Enhancing Oncogenic TAZ Degradation. Biomed. Pharmacother","volume":"155","author":"Cao","year":"2022","journal-title":"Biomedecine Pharm."},{"key":"10.1016\/j.phrs.2024.107526_bib34","article-title":"Artemisinin and Its Derivatives Prevent Helicobacter Pylori-Induced Gastric Carcinogenesis via Inhibition of NF-\u03baB Signaling","volume":"63","author":"Su","year":"2019","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"issue":"10","key":"10.1016\/j.phrs.2024.107526_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.721","article-title":"Liver Cirrhosis: Molecular Mechanisms and Therapeutic Interventions","volume":"5","author":"Dong","year":"2024","journal-title":"MedComm"},{"issue":"5","key":"10.1016\/j.phrs.2024.107526_bib36","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.3390\/ijms23052787","article-title":"Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences","volume":"23","author":"Boulahtouf","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib37","article-title":"Review Article: The Management of Hepatitis A, B, D and Non-A Non-B","volume":"3","author":"Gm","year":"1989","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.phrs.2024.107526_bib38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.1994.03520110065031","article-title":"Epidemiology and Prevention of Hepatitis A in Travelers","volume":"272","author":"Steffen","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.phrs.2024.107526_bib39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/cells11030533","article-title":"The Translational Bridge between Inflammation and Hepatocarcinogenesis","volume":"11","author":"Gufler","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin. Liver Dis."},{"issue":"27","key":"10.1016\/j.phrs.2024.107526_bib41","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3748\/wjg.v25.i27.3527","article-title":"Immune Suppression in Chronic Hepatitis B Infection Associated Liver Disease: A Review","volume":"25","author":"Li","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2024.107526_bib42","doi-asserted-by":"crossref","unstructured":"Liver Cirrhosis. The Lancet 2021, 398 (10308), 1359\u20131376. \u3008https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X\u3009.","DOI":"10.1016\/S0140-6736(21)01374-X"},{"issue":"10","key":"10.1016\/j.phrs.2024.107526_bib43","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic Inflammatory Responses in Liver Fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107526_bib44","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2024.107526_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671640","article-title":"Cellular Mechanisms of Liver Fibrosis","volume":"12","author":"Acharya","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107526_bib46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0040-1708876","article-title":"Hepatic stellate cell-macrophage crosstalk in liver fibrosis and carcinogenesis","volume":"40","author":"Matsuda","year":"2020","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.phrs.2024.107526_bib47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.phrs.2024.107526_bib48","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2021.12.012","article-title":"Therapeutic Potential of Targeting Regulatory Mechanisms of Hepatic Stellate Cell Activation in Liver Fibrosis","volume":"27","author":"Baghaei","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0168-8278(89)90170-0","article-title":"Liver Fibrosis and Extracellular Matrix","volume":"8","author":"Biagini","year":"1989","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib50","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-Induced Hepatocellular Carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107526_bib51","first-page":"399","article-title":"HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep.30231","article-title":"Hepatitis B Virus Core Variants, Liver Fibrosis, and Hepatocellular Carcinoma","volume":"69","author":"Ligat","year":"2019","journal-title":"Hepatol. Baltim. Md"},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/apt.17783","article-title":"Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality","volume":"59","author":"Lee","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2024.107526_bib54","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s10620-021-07048-5","article-title":"Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival","volume":"67","author":"Pinyopornpanish","year":"2022","journal-title":"Dig. Dis. Sci."},{"issue":"21","key":"10.1016\/j.phrs.2024.107526_bib55","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3748\/wjg.v28.i21.2251","article-title":"Viral Hepatitis and Hepatocellular Carcinoma: From Molecular Pathways to the Role of Clinical Surveillance and Antiviral Treatment","volume":"28","author":"Stella","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107526_bib56","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-Dependent Mechanisms of Hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phrs.2024.107526_bib57","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/ijms20061358","article-title":"Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review","volume":"20","author":"Kanda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107526_bib58","doi-asserted-by":"crossref","unstructured":"Sox9\/INHBB Axis-Mediated Crosstalk between the Hepatoma and Hepatic Stellate Cells Promotes the Metastasis of Hepatocellular Carcinoma. Cancer Lett. 2021, 499, 243\u2013254. \u3008https:\/\/doi.org\/10.1016\/j.canlet.2020.11.025\u3009.","DOI":"10.1016\/j.canlet.2020.11.025"},{"issue":"5","key":"10.1016\/j.phrs.2024.107526_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00705-023-05770-1","article-title":"Repurposing of Artesunate, an Antimalarial Drug, as a Potential Inhibitor of Hepatitis E Virus","volume":"168","author":"Bhise","year":"2023","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11262-015-1285-7","article-title":"Artesunate, an Anti-Malarial Drug, Has a Potential to Inhibit HCV Replication","volume":"52","author":"Dai","year":"2016","journal-title":"Virus Genes"},{"key":"10.1016\/j.phrs.2024.107526_bib61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cbi.2017.07.012","article-title":"Antimalarial Agent Artesunate Protects Concanavalin A-Induced Autoimmune Hepatitis in Mice by Inhibiting Inflammatory Responses","volume":"274","author":"Zhao","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"14","key":"10.1016\/j.phrs.2024.107526_bib62","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2217\/imt-2023-0052","article-title":"Role of artesunate in autoimmune diseases and signaling pathways","volume":"15","author":"Gu","year":"2023","journal-title":"Immunotherapy"},{"key":"10.1016\/j.phrs.2024.107526_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1382029","article-title":"The role of inflammasome in chronic viral hepatitis","volume":"14","author":"Wan","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"181","key":"10.1016\/j.phrs.2024.107526_bib64","article-title":"Artesunate Inhibits Lipid Accumulation and Inflammation by Regulating the NLRP3 Inflammasome in Nonalcoholic Fatty Liver Disease","volume":"36","author":"J","year":"2024","journal-title":"Discov. Med"},{"issue":"4","key":"10.1016\/j.phrs.2024.107526_bib65","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3350\/cmh.2024.0222","article-title":"Current Status and Perspective on Molecular Targets and Therapeutic Intervention Strategy in Hepatic Ischemia-Reperfusion Injury","volume":"30","author":"Liu","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107526_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115309","article-title":"The Interrupted Cross-Talk of Inflammatory and Oxidative Stress Trajectories Signifies the Effect of Artesunate against Hepatic Ischemia\/Reperfusion-Induced Inflammasomopathy","volume":"409","author":"Ghoneim","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107526_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.09.035","article-title":"Artesunate Ameliorates Hepatic Fibrosis Induced by Bovine Serum Albumin in Rats through Regulating Matrix Metalloproteinases","volume":"744","author":"Xu","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107526_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105781","article-title":"Artesunate Alleviates Schistosomiasis-Induced Liver Fibrosis by Downregulation of Mitochondrial Complex \u2160 Subunit NDUFB8 and Complex \u2162 Subunit UQCRC2 in Hepatic Stellate Cells","volume":"214","author":"Shen","year":"2021","journal-title":"Acta Trop."},{"issue":"24","key":"10.1016\/j.phrs.2024.107526_bib69","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"S0168-8278","author":"Taru","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107526_bib70","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejphar.2015.08.040","article-title":"Artesunate Alleviates Hepatic Fibrosis Induced by Multiple Pathogenic Factors and Inflammation through the Inhibition of LPS\/TLR4\/NF-\u03baB Signaling Pathway in Rats","volume":"765","author":"Lai","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2024.107526_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026500","article-title":"Expression of P53 in the Effects of Artesunate on Induction of Apoptosis and Inhibition of Proliferation in Rat Primary Hepatic Stellate Cells","volume":"6","author":"Longxi","year":"2011","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.phrs.2024.107526_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011626","article-title":"Mining Host Candidate Regulators of Schistosomiasis-Induced Liver Fibrosis in Response to Artesunate Therapy through Transcriptomics Approach","volume":"17","author":"Yuan","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.phrs.2024.107526_bib73","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.biopha.2018.11.030","article-title":"Artesunate Alleviates Liver Fibrosis by Regulating Ferroptosis Signaling Pathway. Biomed. Pharmacother","volume":"109","author":"Kong","year":"2019","journal-title":"Biomedecine Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib74","doi-asserted-by":"crossref","first-page":"36","DOI":"10.14218\/JCTH.2023.00162","article-title":"Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1\/ATF3 Axis","volume":"12","author":"Wang","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib75","first-page":"14","article-title":"[Effects of Artesunate on Hepatic Fibrosis and Its Mechanism]. Zhongguo Ying Yong Sheng Li Xue Za Zhi Zhongguo Yingyong Shenglixue Zazhi Chin","volume":"31","author":"Du","year":"2015","journal-title":"J. Appl. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib76","first-page":"45","article-title":"Exploring the Effects of Artesunate and Fuzheng Huayu Decoction on Mitochondria in the Treatment of Schistosomiasis Liver Fibrosis]","volume":"30","author":"Luo","year":"2022","journal-title":"Zhonghua Gan Zang Bing. Za Zhi Zhonghua Ganzangbing Zazhi Chin. J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib77","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40360-018-0255-9","article-title":"Artesunate May Inhibit Liver Fibrosis via the FAK\/Akt\/\u03b2-Catenin Pathway in LX-2 Cells","volume":"19","author":"Lv","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107526_bib78","first-page":"1520","article-title":"Artesunate Inhibits Anti-Liver Fibrosis by Blocking the Epithelial-Mesenchymal Transition and Regulating the c-Jun N-Terminal Kinase Pathway","volume":"84","author":"Pan","year":"2022","journal-title":"INDIAN J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.phrs.2024.107526_bib79","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.3748\/wjg.v22.i10.2949","article-title":"Effect of Artesunate Supplementation on Bacterial Translocation and Dysbiosis of Gut Microbiota in Rats with Liver Cirrhosis","volume":"22","author":"Chen","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12876-015-0283-5","article-title":"IL-6, through p-STAT3 Rather than p-STAT1, Activates Hepatocarcinogenesis and Affects Survival of Hepatocellular Carcinoma Patients: A Cohort Study","volume":"15","author":"Kao","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.phrs.2024.107526_bib81","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopha.2016.04.061","article-title":"Artesunate Obliterates Experimental Hepatocellular Carcinoma in Rats through Suppression of IL-6-JAK-STAT Signalling. Biomed. Pharmacother","volume":"82","author":"Ilamathi","year":"2016","journal-title":"Biomedecine Pharm."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2024.107526_bib82","first-page":"158","article-title":"Artemisinin Inhibits in Vitro and in Vivo Invasion and Metastasis of Human Hepatocellular Carcinoma Cells","volume":"18","author":"Weifeng","year":"2011","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"issue":"11","key":"10.1016\/j.phrs.2024.107526_bib83","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1007\/s00204-019-02579-3","article-title":"Artemisinin Suppresses Hepatocellular Carcinoma Cell Growth, Migration and Invasion by Targeting Cellular Bioenergetics and Hippo-YAP Signaling","volume":"93","author":"Li","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107526_bib84","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.yexcr.2016.06.012","article-title":"Artesunate Induces ROS-Dependent Apoptosis via a Bax-Mediated Intrinsic Pathway in Huh-7 and Hep3B Cells","volume":"347","author":"Pang","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"17","key":"10.1016\/j.phrs.2024.107526_bib85","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","article-title":"Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In Vitro and in Vivo Activity, Chemosensitization, and Mechanisms of Action","volume":"14","author":"Hou","year":"2008","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"22","key":"10.1016\/j.phrs.2024.107526_bib86","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2174\/1568026616666160212122820","article-title":"Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma","volume":"16","author":"Ilamathi","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107526_bib87","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.biopha.2017.01.086","article-title":"Artesunate Acts as Fuel to Fire in Sensitizing HepG2 Cells towards TRAIL Mediated Apoptosis via STAT3 Inhibition and DR4 Augmentation","volume":"88","author":"Ilamathi","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbrc.2019.08.115","article-title":"Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma","volume":"519","author":"Jing","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib89","article-title":"Autophagy and cancer: modulation of cell death pathways and cancer cell adaptations","volume":"219","author":"Towers","year":"2020","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.phrs.2024.107526_bib90","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s12276-022-00780-6","article-title":"Preclinical Investigation of Artesunate as a Therapeutic Agent for Hepatocellular Carcinoma via Impairment of Glucosylceramidase-Mediated Autophagic Degradation","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2024.107526_bib91","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.biopha.2018.11.030","article-title":"Artesunate Alleviates Liver Fibrosis by Regulating Ferroptosis Signaling Pathway","volume":"109","author":"Kong","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2024.107526_bib92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2019.04.017","article-title":"Artesunate Protects against Surgery-Induced Knee Arthrofibrosis by Activating Beclin-1-Mediated Autophagy via Inhibition of mTOR Signaling","volume":"854","author":"Wan","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107526_bib93","article-title":"Artesunate Regulates Neurite Outgrowth Inhibitor Protein B Receptor to Overcome Resistance to Sorafenib in Hepatocellular Carcinoma Cells","volume":"12","author":"He","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107526_bib94","first-page":"4735","article-title":"Artesunate and Sorafenib: Combinatorial Inhibition of Liver Cancer Cell Growth","volume":"18","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.phrs.2024.107526_bib95","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","article-title":"Artesunate Synergizes with Sorafenib to Induce Ferroptosis in Hepatocellular Carcinoma","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.phrs.2024.107526_bib96","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/15548627.2023.2261758","article-title":"Artesunate Sensitizes Human Hepatocellular Carcinoma to Sorafenib via Exacerbating AFAP1L2-SRC-FUNDC1 Axis-Dependent Mitophagy","volume":"20","author":"Ma","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2024.107526_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The Role of IL-6\/JAK2\/STAT3 Signaling Pathway in Cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2024.107526_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.06.010","article-title":"STAT3: A Key Regulator in Liver Fibrosis","volume":"21","author":"Zhao","year":"2021","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2024.107526_bib99","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03068-23","article-title":"Stat3 Activation-Triggered Transcriptional Networks Govern the Early Stage of HBV-Induced Hepatic Inflammation","volume":"15","author":"Tang","year":"2024","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41420-024-01995-4","article-title":"IL-17a Promotes Hepatocellular Carcinoma by Increasing FAP Expression in Hepatic Stellate Cells via Activation of the STAT3 Signaling Pathway","volume":"10","author":"Sun","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.phrs.2024.107526_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.801365","article-title":"The Emerging Role of Ferroptosis in Liver Diseases","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107526_bib102","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/0008-5472.CAN-22-3169","article-title":"HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression","volume":"83","author":"Wang","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2024.107526_bib103","unstructured":"Zheng, Y.; Wang, L.; Wang, J.; et al. Modulation of the HIF-1\u03b1-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-Induced Hepatic Stellate Cell Senescence to Explore the Anti-Hepatic Fibrosis Mechanism of Curcumol. \u3008http:\/\/www.eurekaselect.com\u3009."},{"key":"10.1016\/j.phrs.2024.107526_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1258870","article-title":"Recent Progress in the Effect of Ferroptosis of HSCs on the Development of Liver Fibrosis","volume":"10","author":"Tang","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"10.1016\/j.phrs.2024.107526_bib105","first-page":"691","article-title":"Artesunate Induces ER-Derived-ROS-Mediated Cell Death by Disrupting Labile Iron Pool and Iron Redistribution in Hepatocellular Carcinoma Cells","volume":"11","author":"Jiang","year":"2021","journal-title":"Am. J. CANCER Res."},{"key":"10.1016\/j.phrs.2024.107526_bib106","doi-asserted-by":"crossref","unstructured":"Burden of Liver Diseases in the World. J. Hepatol. 2019, 70 (1), 151\u2013171. \u3008https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014\u3009.","DOI":"10.1016\/j.jhep.2018.09.014"},{"issue":"1","key":"10.1016\/j.phrs.2024.107526_bib107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12876-023-03099-2","article-title":"Evaluation of Patients Treated with Direct-Acting Anti-Viral Therapy for Chronic Hepatitis C and Their Risk of Hepatocellular Carcinoma in Hong Kong","volume":"24","author":"Chow","year":"2024","journal-title":"BMC Gastroenterol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107526_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102404","article-title":"High Incidence of Hepatocarcinoma in Patients with Advanced Fibrosis Treated with Direct-Acting Antiviral Agents for Hepatitis C: A Real-World Retrospective Study","volume":"48","author":"Oliveira","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"10","key":"10.1016\/j.phrs.2024.107526_bib109","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/cid\/ciab133","article-title":"Intravenous Artesunate for the Treatment of Severe Imported Malaria: Implementation, Efficacy, and Safety in 1391 Patients","volume":"73","author":"Roussel","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2024.107526_bib110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","article-title":"A Phase I Study of Intravenous Artesunate in Patients with Advanced Solid Tumor Malignancies","volume":"81","author":"Deeken","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107526_bib111","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phrs.2018.02.030","article-title":"Dosing ribavirin in hepatitis E-infected solid organ transplant recipients","volume":"130","author":"De Winter","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.phrs.2024.107526_bib112","first-page":"707","article-title":"[Experimental Studies of Antitumor Effect of Artesunate on Liver Cancer]. Zhongguo Zhong Yao Za Zhi Zhongguo Zhongyao Zazhi China","volume":"26","author":"Wang","year":"2001","journal-title":"J. Chin. Mater. Medica"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:49:37Z","timestamp":1734522577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824004717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":112,"alternative-id":["S1043661824004717"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107526","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107526"}}